European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach

British Journal of Clinical Pharmacology
Robert Vander SticheleESAC Project Group

Abstract

Europe is a continent with strong public healthcare systems, but diverging antibiotic policies and resistance patterns. To describe the performance and methodological approach in a retrospective data collection effort (1997-2001), through an international network of surveillance systems, aiming to collect publicly available, comparable and reliable data on antibiotic use in Europe. A central multidisciplinary management team co-ordinated a network of national representatives, liasing with national data providers and bodies responsible for antibiotic policy. The data collected were screened for bias, using a checklist. We focused on detection bias in sample and census data; errors in assigning medicinal product packages to the Anatomical Therapeutic Chemical Classification (ATC); errors in calculations of defined daily doses (DDD) per package; bias by over-the-counter sales and parallel trade; and bias in ambulatory care (AC)/hospital care (HC) mix. Datasets were corrected after national feedback, and classified as valid; valid but with minor bias; not valid. Of the 31 participating countries, 21 countries delivered AC data suitable for cross-national comparison (14 for all 5 years). Of these, 17 countries provided data on a qua...Continue Reading

References

Aug 14, 1997·The New England Journal of Medicine·M N Swartz
Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M Kunin
Sep 4, 1998·BMJ : British Medical Journal·H Goossens, M J Sprenger
Nov 18, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M Loeb
Jun 19, 2001·Lancet·O CarsA Melander
Apr 3, 2002·Emerging Infectious Diseases·Stef L A M BronzwaerUNKNOWN European Antimicrobial Resistance Surveillance System
May 7, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D L MonnetN Gonzalo
Jun 19, 2002·Scandinavian Journal of Infectious Diseases·Sigvard MölstadOtto Cars
Oct 29, 2002·Patient Education and Counseling·Reginald DeschepperFlora M Haaijer-Ruskamp
Apr 17, 2003·European Journal of Clinical Pharmacology·Marit RønningRobert Vander Stichele

❮ Previous
Next ❯

Citations

Jul 7, 2010·International Journal of Public Health·Giuliano MasieroHerman Goossens
Dec 14, 2004·European Journal of Clinical Pharmacology·J L HovenUNKNOWN DURQUIM Scientific Committee
Jul 22, 2009·European Journal of Clinical Pharmacology·Silvia RaveraJohan J de Gier
Jun 7, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S RiedelG V Doern
Dec 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Angebault, A Andremont
Jun 19, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·M FilippiniG Masiero
Apr 29, 2006·Pharmacy World & Science : PWS·M FerechUNKNOWN ESAC Project Group
Sep 3, 2013·International Journal of Antimicrobial Agents·Niels AdriaenssensHerman Goossens
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dominique L MonnetHerman Goossens
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Herman GoossensUNKNOWN European Surveillance of Antimicrobial Consumption Project Group
May 21, 2008·The Journal of Antimicrobial Chemotherapy·Gérard MoulinUNKNOWN Antimicrobial Resistance ad hoc Group of the French Food Safety Agency
Jul 3, 2008·The Journal of Antimicrobial Chemotherapy·Michael A BorgUNKNOWN ARMed Project Group
Sep 9, 2008·The Journal of Antimicrobial Chemotherapy·Ria BenkoGyöngyvér Soós
Sep 13, 2008·The Journal of Antimicrobial Chemotherapy·Peter DaveyUNKNOWN ESAC Project Group
Apr 23, 2009·The Journal of Antimicrobial Chemotherapy·Samuel CoenenUNKNOWN ESAC Project Group
Feb 10, 2010·The Journal of Antimicrobial Chemotherapy·Niels AdriaenssensUNKNOWN ESAC Project Group
May 31, 2011·The Journal of Antimicrobial Chemotherapy·Niels AdriaenssensUNKNOWN ESAC Project Group
Dec 30, 2011·The Journal of Antimicrobial Chemotherapy·Niels AdriaenssensUNKNOWN ESAC Project Group
May 29, 2012·The Journal of Antimicrobial Chemotherapy·H M KwintUNKNOWN SWAB's Working Group on Surveillance of Antimicrobial Use
Mar 8, 2005·Journal of Clinical Microbiology·Ralf René ReinertFranz-Josef Schmitz
Dec 7, 2007·Quality & Safety in Health Care·Samuel CoenenUNKNOWN ESAC Project Group
Nov 4, 2008·Emerging Infectious Diseases·Nienke van de Sande-BruinsmaUNKNOWN European Surveillance of Antimicrobial Consumption Project Group
Mar 15, 2014·BMC Research Notes·Mònica SabatéUNKNOWN PROTECT Work Package 2
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benedikt Huttner, Matthew Samore
Jul 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald E Low
Oct 1, 2011·Expert Opinion on Drug Safety·Alessandra PugiFrancesco Lapi
Feb 20, 2016·The Journal of Antimicrobial Chemotherapy·Hai LinCecilia Stålsby Lundborg
Oct 17, 2013·Enfermedades infecciosas y microbiología clínica·José Ramón Paño-PardoAntonio Ramos
Oct 17, 2013·Enfermedades infecciosas y microbiología clínica·Santiago GrauLuis Martínez-Martínez
Oct 22, 2015·Pharmacoepidemiology and Drug Safety·Carlos E DuránRobert Vander Stichele
Aug 9, 2011·The Journal of Hospital Infection·C Plüss-SuardG Zanetti
Apr 1, 2011·Drug Discovery Today. Technologies
Jul 23, 2009·Pharmacoepidemiology and Drug Safety·Carlo GagliottiMaria Luisa Moro
Dec 17, 2008·British Journal of Clinical Pharmacology·Emanuel RaschiFabrizio De Ponti
Apr 5, 2013·Tropical Medicine & International Health : TM & IH·V J WirtzR H Vander Stichele
Oct 20, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Limas KupcinskasLeif P Andersen
Nov 26, 2014·Basic & Clinical Pharmacology & Toxicology·Mònica SabatéUNKNOWN PROTECT Work Package 2
Mar 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Mário Miguel RosaCristina Sampaio
Aug 3, 2013·Journal of Chemotherapy·Irina PristašArjana Tambić Andrašević
Nov 24, 2012·Journal of Chemotherapy·Salih Hosoglu, Oguz Karabay
Apr 5, 2016·The Journal of Antimicrobial Chemotherapy·Wiebke SchröderEvelina Tacconelli
Mar 25, 2014·The Lancet Infectious Diseases·Ann VersportenUNKNOWN WHO/Europe-ESAC Project Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved